The Axial Spondyloarthritis Market growth is primarily fueled by an increasing patient population and heightened awareness of AxSpA’s chronic effects. Biologic drugs, physiotherapy solutions, and personalized treatment plans are contributing significantly to market expansion. Patients’ growing preference for effective long-term treatments that prevent disease progression is...